B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Infigratinib

0 PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Infigratinib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

ceritinib
19 shared targets
semaxanib
11 shared targets
mk
13 shared targets
maleimide
12 shared targets
osi
17 shared targets
cabozantinib
14 shared targets
ilorasertib
11 shared targets
brivanib
14 shared targets
tivozanib
14 shared targets
motesanib
15 shared targets
Loading evidence profile...

This evidence profile for Infigratinib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.